Abstract
Routine epidemiological surveillance data represents one of the most continuous and current sources of data during the course of an epidemic. This data is used to calibrate epidemiological forecasting models as well as for public health decision making such as imposition and lifting of lockdowns and quarantine measures. However, such data is generated during testing and contact tracing and not through randomized sampling. Furthermore, since the process of generating this data affects the epidemic trajectory itself – identification of infected persons might lead to them being quarantined, for instance – it is unclear how representative such data is of the actual epidemic itself. For example, will the observed rise in infections correspond well with the actual rise in infections? To answer such questions, we employ epidemiological simulations not to study the effectiveness of different public health strategies in controlling the spread of the epidemic, but to study the quality of the resulting surveillance data and derived metrics and their utility for decision making. Using the BharatSim simulation framework, we build an agent-based epidemiological model with a detailed representation of testing and contact tracing strategies based on those employed in Pune city during the COVID-19 pandemic. Infected persons are identified, quarantined and/or hospitalized based on these strategies, and to generate synthetic surveillance data as well. We perform extensive simulations to study the impact of different public health strategies and availability of tests and contact tracing efficiencies on the resulting surveillance data as well as on the course of the epidemic. The fidelity of the resulting surveillance data in representing the real-time state of the epidemic and in decision-making is explored in the context of Pune city.
Author Summary Through this study, we evaluate the effectiveness of different public health metrics in guiding decision-making during epidemics, using the COVID-19 pandemic in Pune, India, as a case study. We analysed key public health metrics including the test positivity rate (TPR), case fatality rate (CFR), and reproduction number (Rt). Through simulations of the epidemic and the public health response and by varying levels of testing and contact tracing, we assess how these metrics are related to epidemic curves such as infections and deaths. The results show that the rate of change of TPR can help estimate the severity of the outbreak and predict when it will peak. Rt is a strong predictor of the infection peak, but large computed confidence intervals can place strong caveats on its use in decision-making. In contrast, CFR is not useful for predicting the epidemic’s severity or peak,as it tends to peak when the infection curve is on a decline and scales non-linearly with the severity of the epidemic. Overall, our findings highlight that TPR and Rt are valuable tools for real-time epidemic management, while CFR may have limited utility. Through this study, we provide modelling evidence to support the use of some metrics for public-health decision making during epidemics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
PB acknowledges the Department of Science and Technology, Government of India for the KVPY fellowship. SK acknowledges the Department of Science and Technology, Government of India for the INSPIRE fellowship. PC acknowledges support from Ashoka University and the Mphasis F1 Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Anonymized contact tracing data was used to compute the average number of contacts. The Ethics Committee of Indian Institute of Science Education and Research, Pune, India approved the analysis of COVID-19 programmatic data
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Abstract updated; manuscript remains same
Data Availability
All data produced are available online at https://github.com/SoumilK1/Interpreting-epidemiological-surveillance-data
https://github.com/SoumilK1/Interpreting-epidemiological-surveillance-data
